Breast cancer is regarded as as a killer disease and it is famous to be the number one cause of cancer fatality in women. According to American cancer society, about 1.3 million new breast cancer instances are identified every year which includes 465,000 deaths. In order to successfully deal with this disturbing disease, we must push revolutionary scientists to research cancer at its most basic stage. In other words, breast cancer research work should be conducted at its molecular stage. Also, besides the governments, private organizations must give flexible funding to scientists who will be doing breast cancer research work.
Appropriate financial support of breast cancer research projects; can not only lead to improved prevention techniques but it can also help towards earlier diagnostic techniques and new anticancer medication and treatments.
Not so long ago, researchers who are working towards breast cancer research project, have developed and successfully tested a breast cancer vaccine which is probably to cure women with treatment - resistant HER2 - positive breast cancer and therefore be capable to avoid cancer re ? occurrence. Breast cancer scientists anticipate to use HER2 DNA vaccines for cancer-free women, in order to avoid initial development of these tumours. Today therapies such as trastuzumab and lapatimib are utilized towards treating breast cancer patients. However, it was recently noticed that a huge group of patients build up a resistance towards trastuzumab and lapatimib. HER2 receptors are identified to endorse a particularly destructive kind of cancer that includes an estimated thirty percent of breast cancer patients. The latest breast cancer vaccine is produced by the body's own cells. It delivers a cancer fighting gene into cells, which subsequently form immune system proteins as well as tumour ? fighting cells.
According to the lead researcher Wei - Zen Wei, a professor of immunology and microbiology at the Karmanos Cancer Institute, the vaccine is created by using so - called naked DNA from genes that makes the HER2 receptor. This DNA is combined with an immune stimulant. The method involved in the production of the vaccine, is named as electro oration.
In this process, pulses of electricity were used in order to inject the vaccine into the leg muscles in rats. The genes acted towards the cells, which then created HER2 receptors that directed to activation of antibodies and immune cells called Killer T cells. - 30285
Appropriate financial support of breast cancer research projects; can not only lead to improved prevention techniques but it can also help towards earlier diagnostic techniques and new anticancer medication and treatments.
Not so long ago, researchers who are working towards breast cancer research project, have developed and successfully tested a breast cancer vaccine which is probably to cure women with treatment - resistant HER2 - positive breast cancer and therefore be capable to avoid cancer re ? occurrence. Breast cancer scientists anticipate to use HER2 DNA vaccines for cancer-free women, in order to avoid initial development of these tumours. Today therapies such as trastuzumab and lapatimib are utilized towards treating breast cancer patients. However, it was recently noticed that a huge group of patients build up a resistance towards trastuzumab and lapatimib. HER2 receptors are identified to endorse a particularly destructive kind of cancer that includes an estimated thirty percent of breast cancer patients. The latest breast cancer vaccine is produced by the body's own cells. It delivers a cancer fighting gene into cells, which subsequently form immune system proteins as well as tumour ? fighting cells.
According to the lead researcher Wei - Zen Wei, a professor of immunology and microbiology at the Karmanos Cancer Institute, the vaccine is created by using so - called naked DNA from genes that makes the HER2 receptor. This DNA is combined with an immune stimulant. The method involved in the production of the vaccine, is named as electro oration.
In this process, pulses of electricity were used in order to inject the vaccine into the leg muscles in rats. The genes acted towards the cells, which then created HER2 receptors that directed to activation of antibodies and immune cells called Killer T cells. - 30285
About the Author:
Jason Myers is a professional writer and he writes mostly about cancer cure research news. He's also interested in writing cancer information online.
